In cancer, TRPML1 overexpression results in faster growth and improved survival of cells for several cancers, whereas activation of the channel has been reported to be beneficial, for instance, in glioblastoma (Morelli et al., 2019; Santoni et al., 2020). This evidence concerns the gene MCOLN1 and cancer.